In Silico Development of a Multi-Epitope Subunit Vaccine against Bluetongue Virus in Ovis aries Using Immunoinformatics.

IF 3.3 3区 医学 Q2 MICROBIOLOGY
Priyansha Raj Sinha, Shubhada R Hegde, Ruchika Mittal, Chikkamagaluru Chandrashekhar Jagat, Ullas Gowda, Rathna Chandrashekhar, Gayathri Muthaiah, Samer Shamshad, Mohammed Mudassar Chanda, Vishweshwar Ganji, Kalyani Putty, Divakar Hemadri
{"title":"In Silico Development of a Multi-Epitope Subunit Vaccine against Bluetongue Virus in <i>Ovis aries</i> Using Immunoinformatics.","authors":"Priyansha Raj Sinha, Shubhada R Hegde, Ruchika Mittal, Chikkamagaluru Chandrashekhar Jagat, Ullas Gowda, Rathna Chandrashekhar, Gayathri Muthaiah, Samer Shamshad, Mohammed Mudassar Chanda, Vishweshwar Ganji, Kalyani Putty, Divakar Hemadri","doi":"10.3390/pathogens13110944","DOIUrl":null,"url":null,"abstract":"<p><p>The bluetongue virus (BTV), transmitted by biting midges, poses a significant threat to livestock globally. This orbivirus induces bluetongue disease, leading to substantial economic losses in the agricultural sector. The current control measures have limitations, necessitating the development of novel, efficient vaccines. In this study, an immunoinformatics approach is employed to design a multi-epitope subunit vaccine for <i>Ovis aries</i> targeting six BTV serotypes. Focusing on the VP2 capsid protein, the vaccine incorporates B-cell, helper-T lymphocytes (HTL), and cytotoxic T-cell lymphocytes (CTL) epitopes. Molecular docking reveals stable interactions with TLR2 and TLR4 receptors, suggesting the stability of the complex, indicating the potential viability of the multi-epitope vaccine. The computational approach offers a rapid and tailored strategy for vaccine development, highlighting potential efficacy and safety against BTV outbreaks. This work contributes to understanding BTV and presents a promising avenue for effective control.</p>","PeriodicalId":19758,"journal":{"name":"Pathogens","volume":"13 11","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597718/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathogens","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/pathogens13110944","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The bluetongue virus (BTV), transmitted by biting midges, poses a significant threat to livestock globally. This orbivirus induces bluetongue disease, leading to substantial economic losses in the agricultural sector. The current control measures have limitations, necessitating the development of novel, efficient vaccines. In this study, an immunoinformatics approach is employed to design a multi-epitope subunit vaccine for Ovis aries targeting six BTV serotypes. Focusing on the VP2 capsid protein, the vaccine incorporates B-cell, helper-T lymphocytes (HTL), and cytotoxic T-cell lymphocytes (CTL) epitopes. Molecular docking reveals stable interactions with TLR2 and TLR4 receptors, suggesting the stability of the complex, indicating the potential viability of the multi-epitope vaccine. The computational approach offers a rapid and tailored strategy for vaccine development, highlighting potential efficacy and safety against BTV outbreaks. This work contributes to understanding BTV and presents a promising avenue for effective control.

利用免疫信息学技术开发针对猫科动物蓝舌病病毒的多表位亚基疫苗的硅学研究。
由咬蠓传播的蓝舌病病毒(BTV)对全球牲畜构成重大威胁。这种口蹄疫病毒会诱发蓝舌病,给农业部门造成巨大的经济损失。目前的控制措施存在局限性,因此有必要开发新型、高效的疫苗。本研究采用免疫信息学方法设计了一种针对六种蓝耳病血清型的多表位亚单位疫苗。该疫苗以 VP2 表位蛋白为重点,结合了 B 细胞、辅助 T 淋巴细胞 (HTL) 和细胞毒性 T 细胞淋巴细胞 (CTL) 表位。分子对接揭示了与 TLR2 和 TLR4 受体的稳定相互作用,表明了复合物的稳定性,也表明了多表位疫苗的潜在可行性。这种计算方法为疫苗开发提供了一种快速、量身定制的策略,突出了疫苗对乙型脑炎病毒爆发的潜在有效性和安全性。这项工作有助于人们了解 BTV,并为有效控制 BTV 提供了一条前景广阔的途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pathogens
Pathogens Medicine-Immunology and Allergy
CiteScore
6.40
自引率
8.10%
发文量
1285
审稿时长
17.75 days
期刊介绍: Pathogens (ISSN 2076-0817) publishes reviews, regular research papers and short notes on all aspects of pathogens and pathogen-host interactions. There is no restriction on the length of the papers. Our aim is to encourage scientists to publish their experimental and theoretical research in as much detail as possible. Full experimental and/or methodical details must be provided for research articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信